跳至主要内容
临床试验/NCT00920400
NCT00920400已完成不适用

Value of Fecal Calprotectin in Upper Gastrointestinal Disease

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 287 人开始时间: 2008年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
287
试验地点
1

研究概览

简要总结

Fecal calprotectin is a very sensitive non-invasive inflammation marker in the detection of inflammatory bowel disease and, to a lesser degree, has also proven to be useful in adenomatous polyps, neoplasias, and infectious gastroenteritis. Elevated calprotectin levels can also be found in patients with lesion only in the upper gastrointestinal tract. However, the diagnostic value of calprotectin has never been tested in this setting. The aim of the study is therefore to determine the diagnostic value of fecal calprotectin in patients with diseases of the upper gastrointestinal tract.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients referred for upper gastrointestinal endoscopy for any reason
  • Older than 18 years

排除标准

  • Patients who are not able to provide informed consent
  • Patients who are not able to provide a stool sample

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other

研究点 (1)

Loading locations...

相似试验